{
    "Trade/Device Name(s)": [
        "BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K140448",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081825"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "February 20, 2014",
    "Summary Letter Received Date": "February 21, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected female endocervical swab",
        "Clinician-collected male urethral swab",
        "Patient-collected vaginal swab",
        "Male urine (UPT and neat)",
        "Female urine (UPT and neat)",
        "Gynecological specimens in BD SurePath Preservative Fluid",
        "Gynecological specimens in PreservCyt Solution"
    ],
    "Specimen Container(s)": [
        "Swab Diluent",
        "LBC Specimen Dilution Tube",
        "BD SurePath Preservative Fluid",
        "PreservCyt Solution"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper LT System",
        "BD Viper System (Extracted Mode)"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Nucleic acid amplification",
        "DNA probe"
    ],
    "Methodologies": [
        "Molecular NAAT",
        "Qualitative DNA amplification and detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay for qualitative detection of Neisseria gonorrhoeae DNA using SDA technology on BD Viper LT System",
    "Indications for Use Summary": "Qualitative detection of Neisseria gonorrhoeae DNA in various clinician- and patient-collected urogenital swab and urine specimens, as well as gynecological specimens in BD SurePath or PreservCyt fluids, to aid in diagnosis of gonococcal urogenital disease in asymptomatic and symptomatic individuals",
    "fda_folder": "Microbiology"
}